bioAffinity Technologies, Inc. Number of Operating Segments
bioAffinity Technologies, Inc. (BIAF) reported Number of Operating Segments of 2 Segments for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:NumberOfOperatingSegments · last filed 2026-08-07
- bioAffinity Technologies, Inc. number of operating segments for the quarter ending 2026-03-31 was 2.00 Segments, a 0.00% change year-over-year.
- bioAffinity Technologies, Inc. number of operating segments for the quarter ending 2025-03-31 was 2.00 Segments.
- bioAffinity Technologies, Inc. number of operating segments for fiscal 2025 was 2.00 Segments, a 0.00% change from fiscal 2024.
- bioAffinity Technologies, Inc. number of operating segments for fiscal 2024 was 2.00 Segments.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.00 Segments 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 2.00 Segments 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | 2.00 Segments 10-K · filed 2026-03-16 | |||
| 2025-09-30 | 2.00 Segments 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 2.00 Segments 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 2.00 Segments 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | 2.00 Segments 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |